BiotechnologyPharmaceuticalRegulatory Information ManagementRegulatory IntelligenceSoftwareTranslation Services

Cell & Gene Therapy Regulatory Intelligence

IQVIA

Booth: 428

Cell & Gene Therapies are often innovative, high-tech approaches, and the evolving regulatory practices are causing uncertainties that span the entire development process. Whether you are new to this field or established, your regulatory team may struggle to keep up-to-date with the information and understanding of the global regulatory requirements, limiting your ability to develop optimal and cost-effective regulatory strategies. The cell and gene therapies (CGTs) data within the IQVIA Regulatory Intelligence has been developed and is maintained by IQVIA CGT specialists. Collating unique expertise and intelligence from the IQVIA CGT Centre of Excellence, the database gives you access to high-quality and detailed information and guidance on the emerging regulations in the niche CGT market. These insights can support the development of your CGTs all the way through clinical trials and onto the market.

Other product: FDA Advisory Committee Regulatory Intelligence

Other product: Regulatory Intelligence

Other product: Regulatory Intelligence for Medical Device Clinical trials

Other product: Software as a Medical Device Regulatory Intelligence

Website FactsheetBrochure





Request Information





 
By requesting information, you agree to share the email you provided at the time of registration with the exhibitor for follow-up. Click on “Submit” to share your email or “Cancel” to cancel your information request.
 
 
Comments